Featured,Spotlight Stock,Trends & Articles Akome Files for Provisional Patent For Psychedelic Drug Formulation of Mitigating Neurological Damage Due to Stroke By Dennis Mutua June 21, 2021 Biotechnology company developing psychedelic-based pharmaceuticals for rare diseases and mental disorders Akome Biotech Ltd has filed a provisional patent application for development of a next generation psychedelic drug formulati...
Featured,Spotlight Stock Silo Wellness and Halugen Life Sciences Enter Into Psychedelics Genetic Test Kit Partnership By Dennis Mutua June 18, 2021 Life sciences company developing pharmaceutical products which improve health and wellness Silo Wellness (CSE: SILO) (OTCMKTS: SILFF) has entered into a psychedelics genetic test kit partnership with biotechnology company focusing...
Featured,Spotlight Stock,Trends & Articles Etheon Biomedical Set to Acquire Lobo Genetics By Dennis Mutua June 17, 2021 Biotechnology company specializing on developing and commercializing psychedelic therapeutic products for treating mental disorders and addiction Etheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) has announced having entered into...
Featured,Spotlight Stock PharmaTher Files for Pre-Investigational New Drug to Support Clinical Development of KETABET By Dennis Mutua June 16, 2021 Pharmaceutical company specializing on research, development and commercialization of psychedelics PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRM) announced having filed for a pre- investigational new drug (pre-IND) with the Un...
Featured,Spotlight Stock,Trends & Articles Core One Lab on the Verge of Being Granted Patent for Biosynthesized Psilocybin By Dennis Mutua June 14, 2021 Leading life sciences company specializing on bringing psychedelic medicine to the market through novel delivery systems Core One Labs Inc. (CSE: COOL) (OTC: CLABF) is on the verge of getting granted a provisional patent for its b...
Featured,Trends & Articles Cannabis Company Goodness Growth to Launch a Psychedelics Research Division By Dennis Mutua June 11, 2021 Minnesota based medical cannabis company producing pharmaceutical-grade cannabis extracts Goodness Growth Holdings Inc. (CSE: GDNS) (OTCQX: GDNSF) has announced that it will be launching a psychedelics medicine study division. ...
Featured,Spotlight Stock,Trends & Articles Founder and CEO of MindMed J.R. Rahn Stepping Down By Dennis Mutua June 10, 2021 The founder and chief executive officer of psychedelics medicine biotech company discovering, developing and deploying psychedelics inspired medicines Mind Medicine Inc. (MNMD) J.R. Rahn, will be stepping down from the chief execu...
Featured,Spotlight Stock,Trends & Articles Silo Pharma Collaborates With University of California San Francisco to Study Anti-Inflammatory Properties of Psilocybin By Dennis Mutua June 09, 2021 Developmental stage biopharmaceutical company specializing on merging traditional therapeutics and psychedelic research Silo Pharma Inc. (OTCQB: SILO) has joined forces with University California San Francisco to study the propert...